COURTNEY M WESTON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MONROE, LA NPI 1497901805
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LA Acerta Pharma LLC All categories
General Payments — all program years on this page
$5,285.94
- Category: General Payments
- Program years: PY2021–2024
- Record count: 155
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,863.83 across 52 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,863.83 | 52 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $257.36 | 9 |
| GENZYME CORPORATION | $200.02 | 2 |
| Phathom Pharmaceuticals, Inc. | $154.40 | 2 |
| Novo Nordisk AS | $124.80 | 4 |
| BOSTON SCIENTIFIC CORPORATION | $124.17 | 1 |
| Alexion Pharmaceuticals, Inc. | $123.92 | 1 |
| Regeneron Healthcare Solutions, Inc. | $97.62 | 1 |
| Lilly USA, LLC | $97.28 | 5 |
| Dynavax Technologies Corporation | $93.22 | 2 |
| Gilead Sciences, Inc. | $80.79 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $78.88 | 1 |
| ABBVIE INC. | $64.22 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $58.64 | 3 |
| Amgen Inc. | $55.14 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39.93 | 2 |
| PFIZER INC. | $33.55 | 2 |
| Supernus Pharmaceuticals, Inc. | $31.53 | 2 |
| Lexicon Pharmaceuticals, Inc. | $25.18 | 1 |
| ITI, Inc. | $21.81 | 1 |
| Corcept Therapeutics | $20.82 | 1 |
| GlaxoSmithKline, LLC. | $18.86 | 1 |
| Abbott Laboratories | $18.10 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.03 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $14.51 | 1 |
| Exact Sciences Corporation | $14.05 | 1 |
By program year
Records — PY2024 (52)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.